Last edition
News about
WHO launches Global Clinical Trials Forum
The Forum responds to World Health Assembly resolution WHA75.8, which called on WHO to improve the quality and coordination of clinical trials to generate high-quality evidence for health decision-making.
Indigenous Customised TMJ Implant Reflects Growing Strength of India's Medtech Sector: J P Nadda
In a significant breakthrough for India’s medical technology sector, a customised Temporo-Mandibular Joint (TMJ) implant procedure was successfully carried out on four patients by the clinical team at Maulana Azad Institute of Dental Sciences (MAIDS), New Delhi.
Merck Completes Acquisition of Verona Pharma
The acquisition of Verona Pharma strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade.
Omalizumab, the active ingredient in Xolair, is a prescription biologic used to improve the control of severe persistent allergic asthma in patients aged six years and older when blood tests confirm immunoglobulin E (IgE) involvement.
WHO Prequalifies Shanchol Oral Cholera Vaccine
Shanchol remains the only oral cholera vaccine manufactured in India with WHO prequalification, underscoring India’s critical role in ensuring continuity of global supply.
NXP's Trimension UWB Technology Powers Jedsy Medical Delivery Drones
Use of NXP’s Trimension Ultra-Wideband (UWB) technology enables Jedsy drones to accurately detect their position, enabling more challenging maneuvers, such as landing at building windows.
Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm
The new CKD algorithm panel, available on the Navify Algorithm Suite, marks a step in Roche’s strategy to provide digital health solutions for the growing global burden of CKD.
Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share
Rubicon Research Limited has announced the launch of its initial public offering (IPO) of equity shares with a face value of ?1 each, opening on 9 October 2025. The Anchor Investor bidding date is set for 8 October 2025, while the offer will close on 13 October 2025.
<br />
Thermo Fisher and DPIIT Launch BioVerse Challenge to Accelerate 500 Biotech Start-Ups in India
Thermo Fisher Scientific, in collaboration with Startup India and the Department for Promotion of Industry and Internal Trade (DPIIT), has launched the BioVerse Challenge — a nationwide initiative aimed at fast-tracking 500 high-potential biotech start-ups across India over the next three years.
AstraZeneca Partners with Algen Biopharmaceuticals in USD 555 Million Gene Therapy Deal
AstraZeneca has entered into a collaboration and licence agreement valued at up to USD 555 million with United States–based biotechnology company Algen Biopharmaceuticals to develop gene therapies targeting rare diseases.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy